1. Introduction

Delay in delivery affecting viability is an important legal issue in biotechnology, pharmaceutical regulation, medical research, healthcare, biological-material transportation and commercial contracts.

It arises when a supplier, manufacturer, laboratory, logistics company, research institution or healthcare provider fails to deliver biological or temperature-sensitive materials within the prescribed time, resulting in deterioration, contamination, loss of effectiveness or complete destruction of the material.

Unlike ordinary commercial goods, biological materials are often highly time-sensitive. Their usefulness depends not only on their physical condition but also on their biological viability.

Examples include:

Human cells, tissues and organs intended for transplantation.

Embryos, gametes and reproductive biological materials.

Vaccines, blood products and biologics.

Genetically modified organisms and laboratory cultures.

Clinical-trial samples and biological specimens.

Stem cells and gene-therapy products.

The central legal question is whether the delay caused the loss of viability and who should bear responsibility for the resulting damage.

2. Meaning of Viability in Delivery Contracts

Viability refers to the ability of biological material to remain alive, functional, effective or suitable for its intended scientific, medical or commercial purpose.

For example, if a laboratory orders living stem cells for a clinical research project, delivery after the cells have lost their functional properties may amount to a fundamental failure of contractual performance.

Viability can involve several dimensions:

Biological viability: Whether cells, tissues or organisms remain alive and functional.

Clinical viability: Whether the material remains suitable for its intended medical application.

Scientific viability: Whether the material remains suitable for research or experimentation.

Commercial viability: Whether the material retains its agreed marketable quality.

Regulatory viability: Whether the material continues to satisfy applicable storage, transport and safety requirements.

A product may physically arrive at its destination but still be legally defective because it has become biologically unusable.

3. Legal Causes of Delay

Several circumstances may create liability.

A. Negligent transportation

A logistics provider may fail to maintain appropriate temperature, humidity, packaging or transportation conditions.

B. Contractual delivery failure

A supplier may miss a delivery deadline despite knowing that the biological material has a limited usable life.

C. Regulatory obstruction

Customs authorities, import restrictions, missing permits or cross-border documentation requirements may delay delivery.

D. Cold-chain breakdown

Vaccines, cell therapies and biological specimens may lose effectiveness when temperature requirements are violated.

E. Administrative negligence

Hospitals, laboratories or government agencies may cause avoidable delays through poor coordination, documentation errors or unreasonable processing.

F. Force majeure

Unexpected natural disasters, border closures or other extraordinary events may prevent timely delivery. However, a force-majeure clause does not automatically excuse every delay.

4. Important Case Laws

1. Prem Raj Dasari v. Life Cell International Pvt. Ltd.

District Consumer Disputes Redressal Commission, Andhra Pradesh

This is a particularly relevant decision concerning delayed transportation and loss of stem-cell viability.

Facts:

Parents arranged for preservation of their newborn children's umbilical cord blood and tissue.

Samples were collected on 9 January 2015.

They reached the Chennai laboratory on 10 January 2015.

The laboratory reported that one sample had only approximately 63% cell viability.

The parents alleged that transportation delays and inadequate handling had damaged the biological material.

Legal findings:

The Commission examined the contractual transportation obligations and observed that biological samples must reach the laboratory within a reasonable period to minimise loss of viability.

It considered the delay, the transportation arrangements and the laboratory reports while assessing negligence.

Legal principle: A biological-material service provider must exercise reasonable care in collecting, transporting and preserving time-sensitive samples.

CaseMine+1

2. Sequel Logistics Pvt. Ltd. v. Sanwli Sharma & Others (13 November 2024)

National Consumer Disputes Redressal Commission (NCDRC)

Facts:

The dispute concerned delayed transportation of umbilical cord blood and tissue samples intended for stem-cell preservation.

The samples were allegedly routed through Chandigarh and Delhi before reaching Chennai, despite assurances of delivery within approximately 16–18 hours.

The delay allegedly resulted in contamination and failure to process the samples successfully.

Legal significance:

The proceedings concerned the impleadment of the logistics company as a party to the consumer dispute. The case illustrates the importance of examining the responsibilities of transport intermediaries and service providers.

It should not be treated as a final determination of the logistics company's ultimate liability on the merits.

Indian Kanoon+1

3. Sharanya Sinha v. Life Cell International Pvt. Ltd. (28 November 2024)

Consumer appellate proceedings, Delhi

Facts:

The dispute involved the collection and transportation of umbilical cord blood and tissue.

The company informed the customer that the sample had been misplaced during transit and had not reached its laboratory for processing and preservation.

The customer argued that the company had undertaken responsibility for the collection and transportation arrangements.

Legal findings:

The Commission considered the company's responsibility to follow up the collected sample until its delivery to the laboratory.

It applied the principle of res ipsa loquitur in considering the circumstances of the loss and the absence of satisfactory evidence explaining what happened to the sample.

Legal principle: A service provider cannot necessarily escape responsibility by blaming an outside transporter where the transportation arrangement formed part of the service it undertook to provide.

Indian Kanoon

4. Union of India v. Singh Fruit Co. (1973)

Supreme Court of India

Facts:

The case involved delayed delivery of mangoes, a highly perishable commodity.

The consignment was delayed by two days, and approximately 31% damage occurred.

Legal findings:

The Supreme Court recognised that greater care is required when transporting perishable goods. The reasonable delivery period must be assessed in light of the nature of the goods.

The railway administration was expected to explain how the consignment had been handled during transit.

Legal principle: The more perishable the goods, the stricter the practical standard of timely and careful transportation. This reasoning is relevant by analogy to biological materials whose viability declines with time.

Indian Kanoon

5. Swarna Kataru v. Life Cell International Pvt. Ltd.

National Consumer Disputes Redressal Commission

Facts:

The dispute concerned contamination of preserved cord-tissue stem-cell material and a substantial delay in informing the customer about the contamination.

Legal findings:

The Commission considered the delay in communication, the preservation process and the service provider's responsibility for proper handling.

It awarded compensation of ₹2 lakh, a partial refund of ₹35,050 with interest, and litigation costs of ₹1 lakh.

However, the Commission did not accept speculative future medical benefits as proof of substantial consequential injury.

Legal principle: Negligence in preserving biological material can constitute deficiency in service, but compensation must be supported by evidence and cannot automatically be based on hypothetical future benefits.

CaseMine

5. Legal Principles Governing Delay and Viability

Several legal doctrines determine whether delayed delivery creates liability.

A. Doctrine of reasonable time

The delivery period must be assessed according to the nature and sensitivity of the material.

A delay of 24 hours may be harmless for ordinary equipment but potentially disastrous for certain biological samples.

B. Duty of care

The supplier, transporter and laboratory must exercise reasonable professional care.

This duty may include:

Appropriate packaging.

Temperature monitoring.

Timely dispatch.

Proper route selection.

Tracking and documentation.

Immediate communication about delays.

Appropriate emergency arrangements.

C. Causation

The claimant must establish a connection between the delay and the loss of viability.

For example, laboratory reports, temperature records, transportation logs and expert evidence may demonstrate that the delay caused deterioration.

D. Foreseeability of loss

Where a supplier knows that a biological sample has a limited viable period, the possibility of deterioration through delay is foreseeable.

E. Res ipsa loquitur

This doctrine means that the circumstances of an incident may themselves support an inference of negligence where the event ordinarily would not happen without inadequate care and the relevant process was under the defendant's control.

It does not automatically establish liability in every transportation failure.

6. Statutory Framework in India

The following laws may be relevant depending on the nature of the biological material and the contractual relationship.

The applicable statutory provisions depend on whether the transaction concerns a commercial product, a professional service, human biological material or a regulated medical activity.

7. Liability of Different Parties

Responsibility may be distributed among several participants.

Importantly, liability is not automatic merely because several parties participated in transportation. Their contractual duties, control over the material and contribution to the damage must be established.

8. Defences Available to the Service Provider

A defendant may raise several legal defences:

Force majeure: An extraordinary event genuinely prevented timely delivery.

Customer negligence: The customer failed to provide necessary documents or instructions.

Pre-existing deterioration: The material was already defective or non-viable before collection.

Contractual limitations: The agreement clearly allocated particular transportation risks.

Absence of causation: The delay did not cause the loss of viability.

Scientific uncertainty: The material failed viability testing for reasons unrelated to transportation.

However, contractual exclusions cannot automatically protect a service provider against its own negligence, statutory violations or deficiency in service.

9. Evidence Required to Establish Liability

Scientific and documentary evidence is especially important in these disputes.

The claimant should preserve:

Collection and dispatch records.

Delivery receipts and timestamps.

Temperature-monitoring records.

Cold-chain transportation reports.

Laboratory viability assessments.

Cell-count and contamination reports.

Expert scientific opinions.

Contractual delivery commitments.

Emails and communications concerning delays.

Evidence of financial loss and additional expenses.

The most important question is whether the biological material was viable when collected and whether the delay materially contributed to its subsequent deterioration.

10. Compensation and Remedies

Depending on the applicable law and evidence, an affected party may seek:

1. Refund: Recovery of the amount paid for unsuccessful services.

2. Compensatory damages: Compensation for established financial loss caused by the delay.

3. Consumer compensation: Compensation for deficiency in service, mental agony and other legally recognised injuries.

4. Replacement or alternative performance: Where scientifically and legally possible.

5. Litigation costs: Recovery of reasonable legal expenses where awarded.

6. Regulatory action: Complaints to appropriate authorities where the conduct also involves regulatory violations.

A particularly difficult issue arises when the material cannot be replaced. For example, the loss of a newborn's umbilical cord blood sample may represent the permanent loss of a one-time preservation opportunity. Nevertheless, the amount of compensation must be determined through applicable legal principles and evidence rather than automatically equating the loss with the maximum possible future medical benefit.

11. Critical Legal Issues and Emerging Challenges

Modern biotechnology creates several unresolved legal challenges:

Who bears responsibility when international customs clearance delays the delivery of biological materials?

Can a logistics company be held liable for failure to maintain the cold chain?

Should biological-material delivery contracts contain mandatory emergency transportation provisions?

How should courts calculate compensation when a unique biological specimen is permanently lost?

Can a company rely on contractual disclaimers despite failing to disclose foreseeable transportation risks?

What happens when the material remains physically intact but loses its therapeutic effectiveness?

These questions are particularly significant for international cell-therapy supply chains, reproductive biotechnology, organ transplantation and personalised medicine.

12. Conclusion

Delay in delivery affecting viability represents a distinctive intersection of contract law, consumer protection, scientific evidence, medical negligence and biotechnology regulation.

The cases involving Life Cell International demonstrate that timely transportation, proper handling, preservation and transparent communication can be legally significant obligations.

The decision in Union of India v. Singh Fruit Co. further illustrates that reasonable delivery time must be assessed in light of the perishable nature of the goods.

The fundamental legal principle is that delivery is not necessarily successful merely because the material physically reaches its destination. It must also retain the quality, functionality and viability required by the contract and applicable law.

Where negligent delay causes irreversible biological deterioration, the responsible service provider may face contractual, consumer-law or other appropriate legal consequences.

Research note: The Indian decisions discussed above are especially useful for studying stem-cell transportation and preservation disputes. Their procedural status and jurisdiction should be checked against the original orders before relying on them in formal legal proceedings. This is particularly important when distinguishing an interim procedural decision from a final ruling on liability.